OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 76. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Diplopia and Ptosis in an Older Woman	811
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	509
Somebody to Love	509
Error in Author Name	378
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	307
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	301
Equipping AI for Unbiased and Inclusive Neurology	273
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	262
Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials	253
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio	245
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	245
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	239
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	218
Early vs Delayed Extubation After Thrombectomy for Acute Ischemic Stroke	212
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease	202
Efficacy and Safety of Ecopipam for Tourette Syndrome	202
The Machine Is Just as Loud	191
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	182
Automated Imaging Differentiation for Parkinsonism	177
Origin of Transthyretin in Cerebral Amyloid Angiopathy	170
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	168
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	162
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	152
JAMA Neurology	142
JAMA Neurology	141

Is It Really Itching?	140
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis	136
The Neurologist’s Imperative in Brain Death	136
Endovascular Therapy for Basilar Occlusions—The ATTENTION Trial	133
External Carotid Artery Angioplasty Based on Ultrahigh-Resolution Photon-Counting CTA	133
Time to Change the Current Clinical Classification of Multiple Sclerosis?	132
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	132
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	131
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	129
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	127
Thrombolysis With Tenecteplase for Minor Disabling Stroke	125
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	125
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	124
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	123
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	121
Histologic Anatomy of Neurocysticercosis	118
Error in Abstract	118
Error in Additional Contributions	118
Genetic Testing by Age at Onset in Parkinson Disease	113
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	113
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	111
Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation	110
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	106
Error in Figure	98
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	97
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	96
Is It Really Itching?—Reply	95
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	93
JAMA Neurology	93
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	91
Five Years of Ublituximab in Multiple Sclerosis	90
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	90
Do Neurologists Need a Goldwater Rule?	90
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	90
Self-Reported Seizure Durations	88
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy	88
Wind Swirl Pattern on Density Spectral Array in Anti-GABAB Receptor Encephalitis With Amnestic Seizures	86
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	85
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease	85
Interhemispheric Bullet Migration—A Surgical Dilemma	85
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	85
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	83
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	82
Role of the X Chromosome in Alzheimer Disease Genetics	82
Error in Text	81
Error in the Strengths and Limitations	81
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	78
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	77
Tilting at Treadmills—Pitfalls and Potential of Dementia Prevention Trials	77
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	77

JAMA Neurology